Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
Clinical trial NCT00887068 · COMPLETED
Trial details
- NCT number
- NCT00887068
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-21
- Primary completion
- 2018-08-20
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.